Market Place
Sourcing Support
Qilu Pharmaceutical`s Generics Sugammadex Receives Tentative Approval in US
28 Aug 2024 //
FDA
Acquired approval for manufacturing and marketing generic drugs
15 Aug 2024 //
PRESS RELEASE
We Are Happy To Announce Sugammadex APIs Has Been Approved By Japanese
27 May 2024 //
PRESS RELEASE
Eugia Pharma`s Generic Sugammadex Receives Approval in the U.S.
03 Nov 2023 //
FDA
Sandoz B2B`s Generic Sugammadex Receives Approval in the U.S.
13 Oct 2023 //
FDA
Zydus Pharmaceuticals` Generic Sugammadex Receives Approval in the U.S.
04 Oct 2023 //
FDA
Piramal Critical`s sugammadex Receives Approval in Europe
18 Jul 2023 //
EMA
AOP Orphan`s Sugammadex Approved In Europe
06 Jul 2023 //
EMA
Extrovis` Sugammadex Receives Approval in Europe
16 Jun 2023 //
EMA
Mylan`s Generic Sugammadex Sodium Receives Approval in the U.S.
15 Jun 2023 //
FDA
Merck says court ruled in favor over patent-infringement suit Related to BRIDION
14 Jun 2023 //
PRESS RELEASE
Aspiro`s Generic Sugammadex Sodium Receives Approval in the U.S.
09 Jun 2023 //
FDA
AOP Orphan`s Sugammadex Amomed Receives Approval in Europe
13 Jan 2023 //
EMA
AOP Orphan`s Sugammadex Amomed (Sugammadex) Receives Approval in Europe
13 Jan 2023 //
EMA
Zydus receives USFDA tentative approval for Sugammadex Injection
16 Sep 2022 //
BUSINESS-STANDARD
Zydus gets tentative approval from USFDA for Sugammadex Injection
16 Sep 2022 //
ECONOMICTIMES
Fresenius Kabi`s Sugammadex Receives Approval in the EMA
21 Jul 2022 //
EMA
Mylan`s Sugammadex Mylan (sugammadex sodium) Receives Approval in Europe
22 Nov 2021 //
EMA
Gland Pharma receives US FDA tentative approval for generic Bridion injection
09 Oct 2021 //
PHARMABIZ
Gland Pharma gets tentative nod from USFDA for generic Sugammadex injection
08 Oct 2021 //
ECONOMIC TIMES
Sugammadex Sodium API – CADIFA Approval by ANVISA
06 Oct 2021 //
PRESS RELEASE
Recent developments of Sugammadex Sodium in the wake period of anesthesia
27 Sep 2021 //
PRESS RELEASE
Introducing Sugammadex Sodium made by Medichem
16 Oct 2020 //
PRESS RELEASE
First European APIs, Sugammadex and Apixaban, filed to the NMPA
21 Mar 2019 //
PRESS RELEASE
Study Stopped as Merck & Co. Immunotherapy Drug Wows in Bladder Cancer Trial
22 Oct 2016 //
BIOSPACE
Copyright © 2024 LePro PharmaCompass OPC Private Limited, All rights reserved.